Effect of injection zoledronic acid given directly into the giant cell tumour of bone
- Conditions
- Health Condition 1: D169- Benign neoplasm of bone and articular cartilage, unspecified
- Registration Number
- CTRI/2024/01/062092
- Lead Sponsor
- All India Institute of Medical Sciences , Rishikesh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. All the patients of biopsy proven GCT with aggressiveness on radiology (campanacci
grade 3) will be included
2. Patient who consents for the study
3. Male or female > 18 years of age
4. Histologically proven GCT of axial and appendicular skeleton
5. Recurrent GCT
6. Pathological fracture in GCT
7. Patient with normal renal function test and serum calcium levels
8. Patients who comply with adequate follow-up
? Other previous malignancy within 5 years, with exception of a history of a previous
basal cell carcinoma of the skin or pre-invasive carcinoma of the cervix
? Known hypersensitivity reaction to drug used
? Pregnancy or lactating
? Medical or psychological condition which in the opinion of the investigator would not
permit the patient to complete the study or sign meaningful informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method